======= SETDB2 ======= == Gene Information == * **Official Symbol**: SETDB2 * **Official Name**: SET domain bifurcated histone lysine methyltransferase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83852|83852]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96T68|Q96T68]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SETDB2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SETDB2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607865|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Histone methyltransferase involved in left-right axis specification in early development and mitosis. Specifically trimethylates 'Lys-9' of histone H3 (H3K9me3). H3K9me3 is a specific tag for epigenetic transcriptional repression that recruits HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Contributes to H3K9me3 in both the interspersed repetitive elements and centromere-associated repeats. Plays a role in chromosome condensation and segregation during mitosis. {ECO:0000269|PubMed:20404330}. |MBD| |SET| |Pre-SET| |histone methyltransferase activity (H3-K9 specific)| |left/right axis specification| |histone H3-K9 methylation| |histone H3-K9 modification| |left/right pattern formation| |heart looping| |embryonic heart tube morphogenesis| |determination of heart left/right asymmetry| |histone lysine methylation| |embryonic heart tube development| |axis specification| |peptidyl-lysine methylation| |histone methylation| |determination of left/right symmetry| |determination of bilateral symmetry| |chromosome| |specification of symmetry| |protein alkylation| |protein methylation| |heart morphogenesis| |macromolecule methylation| |chromosome segregation| |embryonic organ morphogenesis| |epithelial tube morphogenesis| |methylation| |peptidyl-lysine modification| |regionalization| |histone modification| |covalent chromatin modification| |morphogenesis of an epithelium| |embryonic organ development| |pattern specification process| |cell division| |heart development| |tissue morphogenesis| |embryonic morphogenesis| |tube morphogenesis| |mitotic cell cycle| |chromatin organization| |zinc ion binding| |tube development| |circulatory system development| |peptidyl-amino acid modification| |animal organ morphogenesis| |embryo development| |chromosome organization| |epithelium development| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| |tissue development| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|-1.88| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|1.82| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17217 * **Expression level (log2 read counts)**: 5.74 {{:chemogenomics:nalm6 dist.png?nolink |}}